UniProt ID | NUAK2_HUMAN | |
---|---|---|
UniProt AC | Q9H093 | |
Protein Name | NUAK family SNF1-like kinase 2 | |
Gene Name | NUAK2 {ECO:0000312|EMBL:AAH17306.1} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 628 | |
Subcellular Localization | ||
Protein Description | Stress-activated kinase involved in tolerance to glucose starvation. Induces cell-cell detachment by increasing F-actin conversion to G-actin. Expression is induced by CD95 or TNF-alpha, via NF-kappa-B. Protects cells from CD95-mediated apoptosis and is required for the increased motility and invasiveness of CD95-activated tumor cells. Able to phosphorylate 'Ser-464' of LATS1.. | |
Protein Sequence | MESLVFARRSGPTPSAAELARPLAEGLIKSPKPLMKKQAVKRHHHKHNLRHRYEFLETLGKGTYGKVKKARESSGRLVAIKSIRKDKIKDEQDLMHIRREIEIMSSLNHPHIIAIHEVFENSSKIVIVMEYASRGDLYDYISERQQLSEREARHFFRQIVSAVHYCHQNRVVHRDLKLENILLDANGNIKIADFGLSNLYHQGKFLQTFCGSPLYASPEIVNGKPYTGPEVDSWSLGVLLYILVHGTMPFDGHDHKILVKQISNGAYREPPKPSDACGLIRWLLMVNPTRRATLEDVASHWWVNWGYATRVGEQEAPHEGGHPGSDSARASMADWLRRSSRPLLENGAKVCSFFKQHAPGGGSTTPGLERQHSLKKSRKENDMAQSLHSDTADDTAHRPGKSNLKLPKGILKKKVSASAEGVQEDPPELSPIPASPGQAAPLLPKKGILKKPRQRESGYYSSPEPSESGELLDAGDVFVSGDPKEQKPPQASGLLLHRKGILKLNGKFSQTALELAAPTTFGSLDELAPPRPLARASRPSGAVSEDSILSSESFDQLDLPERLPEPPLRGCVSVDNLTGLEEPPSEGPGSCLRRWRQDPLGDSCFSLTDCQEVTATYRQALRVCSKLT | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MESLVFAR -------CCCCEECC | 7.72 | 22814378 | |
30 | Phosphorylation | LAEGLIKSPKPLMKK HHHHHCCCCHHHHCH | 31.03 | 30576142 | |
58 | Phosphorylation | HRYEFLETLGKGTYG HHHHHHHHHCCCCCC | 42.85 | - | |
64 | Phosphorylation | ETLGKGTYGKVKKAR HHHCCCCCCCHHHHH | 24.50 | 20049867 | |
73 | Phosphorylation | KVKKARESSGRLVAI CHHHHHHCCCCEEEE | 32.32 | 29038488 | |
74 | Phosphorylation | VKKARESSGRLVAIK HHHHHHCCCCEEEEE | 24.15 | 29038488 | |
125 | Ubiquitination | VFENSSKIVIVMEYA HHHCCCEEEEEEEEC | 2.49 | - | |
131 | Phosphorylation | KIVIVMEYASRGDLY EEEEEEEECCCCCHH | 7.56 | 22817900 | |
133 | Phosphorylation | VIVMEYASRGDLYDY EEEEEECCCCCHHHH | 35.57 | 25072903 | |
138 | Phosphorylation | YASRGDLYDYISERQ ECCCCCHHHHHHHHH | 16.08 | 25072903 | |
140 | Phosphorylation | SRGDLYDYISERQQL CCCCHHHHHHHHHHC | 7.87 | 25072903 | |
142 | Phosphorylation | GDLYDYISERQQLSE CCHHHHHHHHHHCCH | 22.09 | 25072903 | |
208 | Phosphorylation | HQGKFLQTFCGSPLY HCCCHHHHHCCCCCC | 24.04 | 14976552 | |
252 | Phosphorylation | HGTMPFDGHDHKILV HCCCCCCCCCCEEEE | 28.62 | 14976552 | |
267 | Phosphorylation | KQISNGAYREPPKPS EEECCCCCCCCCCHH | 19.53 | 19702290 | |
289 | Phosphorylation | WLLMVNPTRRATLED HHHHHCCCCCCCHHH | 27.81 | 28270605 | |
311 | Phosphorylation | NWGYATRVGEQEAPH CCCCEEEECCCCCCC | 9.57 | - | |
355 | Acetylation | AKVCSFFKQHAPGGG HHHHHHHHHHCCCCC | 38.88 | 26051181 | |
416 | Phosphorylation | GILKKKVSASAEGVQ CHHHHHHCCCCCCCC | 25.94 | 25627689 | |
418 | Phosphorylation | LKKKVSASAEGVQED HHHHHCCCCCCCCCC | 21.24 | 25627689 | |
430 | Phosphorylation | QEDPPELSPIPASPG CCCCCCCCCCCCCCC | 21.08 | 25627689 | |
435 | Phosphorylation | ELSPIPASPGQAAPL CCCCCCCCCCCCCCC | 24.98 | 22817900 | |
457 | Phosphorylation | KKPRQRESGYYSSPE CCCCCCCCCCCCCCC | 33.99 | 20071362 | |
461 | Phosphorylation | QRESGYYSSPEPSES CCCCCCCCCCCCCCC | 30.82 | 29802988 | |
462 | Phosphorylation | RESGYYSSPEPSESG CCCCCCCCCCCCCCC | 19.70 | 22817900 | |
466 | Phosphorylation | YYSSPEPSESGELLD CCCCCCCCCCCCCCC | 42.61 | 28348404 | |
468 | Phosphorylation | SSPEPSESGELLDAG CCCCCCCCCCCCCCC | 41.74 | 29759185 | |
479 | Phosphorylation | LDAGDVFVSGDPKEQ CCCCCEEECCCCHHC | 6.67 | - | |
506 | Phosphorylation | KGILKLNGKFSQTAL CCEEEECCEECHHHH | 42.70 | - | |
519 | Phosphorylation | ALELAAPTTFGSLDE HHHHHCCCCCCCHHH | 29.99 | 20071362 | |
520 | Phosphorylation | LELAAPTTFGSLDEL HHHHCCCCCCCHHHC | 25.58 | 28348404 | |
523 | Phosphorylation | AAPTTFGSLDELAPP HCCCCCCCHHHCCCC | 28.58 | 22817900 | |
531 | Ubiquitination | LDELAPPRPLARASR HHHCCCCCCCCCCCC | 37.49 | - | |
540 | Phosphorylation | LARASRPSGAVSEDS CCCCCCCCCCCCCCC | 37.97 | 19369195 | |
544 | Phosphorylation | SRPSGAVSEDSILSS CCCCCCCCCCCCCCC | 34.84 | 22817900 | |
547 | Phosphorylation | SGAVSEDSILSSESF CCCCCCCCCCCCCCC | 22.75 | 22817900 | |
550 | Phosphorylation | VSEDSILSSESFDQL CCCCCCCCCCCCCCC | 30.32 | 19369195 | |
553 | Phosphorylation | DSILSSESFDQLDLP CCCCCCCCCCCCCCC | 35.75 | 22817900 | |
567 | Phosphorylation | PERLPEPPLRGCVSV CHHCCCCCCCCCEEE | 32.78 | - | |
573 | Phosphorylation | PPLRGCVSVDNLTGL CCCCCCEEECCCCCC | 28.03 | 28348404 | |
588 | Phosphorylation | EEPPSEGPGSCLRRW CCCCCCCCCHHHHHH | 27.72 | - | |
591 | Phosphorylation | PSEGPGSCLRRWRQD CCCCCCHHHHHHCCC | 4.20 | - | |
597 | Phosphorylation | SCLRRWRQDPLGDSC HHHHHHCCCCCCCCC | 50.11 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
208 | T | Phosphorylation | Kinase | STK11 | Q15831 | PhosphoELM |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
208 | T | Phosphorylation |
| 14976552 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NUAK2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
A4_HUMAN | APP | physical | 21832049 | |
LATS1_HUMAN | LATS1 | physical | 19927127 | |
LZTR1_HUMAN | LZTR1 | physical | 28514442 | |
MYPT1_HUMAN | PPP1R12A | physical | 28514442 | |
MARK3_HUMAN | MARK3 | physical | 28514442 | |
UBXN7_HUMAN | UBXN7 | physical | 28514442 | |
FLNC_HUMAN | FLNC | physical | 28514442 | |
FBW1A_HUMAN | BTRC | physical | 28514442 | |
SAHH3_HUMAN | AHCYL2 | physical | 28514442 | |
MARK2_HUMAN | MARK2 | physical | 28514442 | |
FBW1B_HUMAN | FBXW11 | physical | 28514442 | |
DCAF5_HUMAN | DCAF5 | physical | 28514442 | |
UBP7_HUMAN | USP7 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-435; SER-462; SER-523;SER-540; SER-544; SER-547; SER-550 AND SER-553, AND MASS SPECTROMETRY. | |
"LKB1 is a master kinase that activates 13 kinases of the AMPKsubfamily, including MARK/PAR-1."; Lizcano J.M., Goeransson O., Toth R., Deak M., Morrice N.A.,Boudeau J., Hawley S.A., Udd L., Maekelae T.P., Hardie D.G.,Alessi D.R.; EMBO J. 23:833-843(2004). Cited for: NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 205-224, FUNCTION,ENZYME REGULATION, PHOSPHORYLATION AT THR-208, AND MUTAGENESIS OFTHR-208. |